Filing Details

Accession Number:
0001123292-15-000713
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-17 17:33:26
Reporting Period:
2015-04-15
Filing Date:
2015-04-17
Accepted Time:
2015-04-17 17:33:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
21665 Colgate Palmolive Co CL Perfumes, Cosmetics & Other Toilet Preparations (2844) 131815595
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1290501 Patricia Verduin C/O Colgate-Palmolive Company
300 Park Avenue
New York NY 10022
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-15 3,333 $36.61 51,181 No 4 M Direct
Common Stock Disposition 2015-04-15 3,333 $69.89 47,848 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-04-15 3,333 $0.00 3,333 $36.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,332 2015-09-10 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,422 Indirect By Issuer's 401(k) Plan Trustee
Footnotes
  1. Exercise of stock options awarded under the issuer's employee stock option plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's employee stock option plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $69.72 to $70.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2009 grant date.